FDA Adverse Event Malfunction Summary report: N

ELECSYS FSH

MDR report key: 23866549 · Received December 22, 2025

Report

Report Number
1823260-2025-05288
Event Type
Malfunction
Date Received
December 22, 2025
Date of Event
December 1, 2025
Report Date
April 3, 2026
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CGJ
UDI-DI
07613336170380
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SAMPLE WAS RECEIVED FOR INVESTIGATION. DURING THE INVESTIGATION, AN INTERFERING FACTOR WAS DETECTED IN THE SAMPLE. THE PRODUCT LABELING STATES: "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN. FOR DIAGNOSTIC PURPOSES, THE RESULTS SHOULD ALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT¿S MEDICAL HISTORY, CLINICAL EXAMINATION AND OTHER FINDINGS." A GENERAL PRODUCT PROBLEM CAN BE EXCLUDED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT WAS DUE TO A KNOWN INTERFERENCE.

Additional Manufacturer Narrative · 0

THE FT4 REAGENT LOT NUMBER WAS 89174503 WITH AN EXPIRATION DATE OF 30-SEP-2026. THE FT3 REAGENT LOT NUMBER WAS 84914201 WITH AN EXPIRATION DATE OF 30-APR-2026. THE ANTI-TG REAGENT LOT NUMBER WAS 84585101 WITH AN EXPIRATION DATE OF 31-JAN-2026. THE VITAMIN D TOTAL REAGENT LOT NUMBER WAS 88165901 WITH AN EXPIRATION DATE OF 30-SEP-2026. THE SHBG REAGENT LOT NUMBER WAS 81508501 WITH AN EXPIRATION DATE OF 31-DEC-2025. THE TESTOSTERONE REAGENT LOT NUMBER WAS 83395801 WITH AN EXPIRATION DATE OF 31-MAR-2026. THE CORTISOL REAGENT LOT NUMBER WAS 88552701 WITH AN EXPIRATION DATE OF 31-JUL-2026. THE PROLACTIN REAGENT LOT NUMBER WAS 82669801 WITH AN EXPIRATION DATE OF 31-MAR-2026. THE FSH REAGENT LOT NUMBER WAS 85544702 WITH AN EXPIRATION DATE OF 31-AUG-2026. THE SAMPLE WAS REQUESTED FOR INVESTIGATION. INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT¿S SAMPLE TESTED WITH ELECSYS FT4 IV ASSAY, ELECSYS FT3 III ASSAY, ELECSYS VITAMIN D TOTAL III ASSAY, ELECSYS SHBG ASSAY, ELECSYS TESTOSTERONE II ASSAY, ELECSYS CORTISOL II ASSAY, ELECSYS PROLACTIN II ASSAY, ELECSYS FSH ASSAY, AND ELECSYS ANTI-TG ASSAY ON A COBAS E 801 ANALYTICAL UNIT. THIS MEDWATCH WILL APPLY TO THE FSH ASSAY. PLEASE REFER TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE VITAMIN D TOTAL III ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE SHBG ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE TESTOSTERONE II ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER(B)(6) FOR INFORMATION RELATED TO THE FT3 III ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE CORTISOL II ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE PROLACTIN II ASSAY, TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE FT4 IV ASSAY, AND TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE ANTI-TG ASSAY. FSH: INITIAL RESULT: <1.00 U/L. REPEAT RESULT: 4.9 U/L. PROLACTIN: INITIAL RESULT: 2.3 G/L. REPEAT RESULT: 4.9 G/L. CORTISOL: INITIAL RESULT: 29.3 G/DL. REPEAT RESULT: 14.9 G/DL. TESTOSTERONE: INITIAL RESULT: 1320 NG/DL. REPEAT RESULT: 361 NG/DL. SHBG: INITIAL RESULT: 13.6 NMOL/L. REPEAT RESULT: 31.3 NMOL/L. VITAMIN D: INITIAL RESULT: 40.5 NMOL/L. REPEAT RESULT: 6 G/L. FT4: INITIAL RESULT: >100 PMOL/L. REPEAT RESULT: 17.7 PMOL/L. FT3: INITIAL RESULT: 13.1 PMOL/L. REPEAT RESULT: 5.61 PMOLL. ANTI-TG: INITIAL RESULT: 2000 KU/L. REPEAT RESULT: <1.30 IU/ML. THE SAMPLE WAS REPEATED ON A SIEMENS ANALYZER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2402208 ELECSYS FSH RADIOIMMUNOASSAY, FOLLICLE-STIMULATING HORMONE CGJ ROCHE DIAGNOSTICS 85544702 07613336170380

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown